Avandia FDA panel diabetes drug

Avandia fell from its perch atop the diabetes drug market amid safety concerns.

( Justin Sullivan / Getty Images / May 21, 2007 )

Avandia fell from its perch atop the diabetes drug market amid safety concerns.

  • Email E-mail
  • add to Twitter Twitter
  • add to Facebook Facebook

PLAN AHEAD

Top Trending Videos